Boehringer Ingelheim

July 2020 •
36 pages •
Report ID: 5780232 •
Format: PDF

Summary
Table of contents

PharmaVitae explores Boehringer Ingelheim’s prescription pharmaceutical performance and outlook over 2019–29.

Snapshot
Overview – Boehringer Ingelheim will see near-term growth, but will see long-term revenue declines because of fewer NMEs in its late-stage pipeline compared to its peers.
Key themes – [1] Upcoming label expansions for Jardiance should help to sustain recent robust revenue trends [2] Ofev should see continued growth in idiopathic pulmonary fibrosis (IPF) and interstitial lung disease associated with systemic sclerosis (SSc-ILD) [3] Boehringer Ingelheim will see royalties from Skyrizi, which has already become a blockbuster product for AbbVie.

Model updates (20 May 2020)

Jardiance forecast adjusted higher
Glyxambi forecast removed due to Boehringer not providing brand-level revenue performance
Stiolto forecast removed due to Boehringer not providing brand-level revenue performance.

Model updates (6 August 2019)

Ofev forecast adjusted higher due to market share gains within IPF
Jardiance forecast adjusted higher due to strong growth.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager

Boehringer Ingelheim

Our reports have been used by over 10K customers, including:

Related reports and data

Topic: Prescription Drug

Parent Industry